--- title: "Amasse Capital Files HKEX Disclosure on Share Capital Increase With (Number) New Shares at (Price) Each" type: "News" locale: "en" url: "https://longbridge.com/en/news/274626487.md" datetime: "2026-02-03T09:03:34.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/274626487.md) - [en](https://longbridge.com/en/news/274626487.md) - [zh-HK](https://longbridge.com/zh-HK/news/274626487.md) --- # Amasse Capital Files HKEX Disclosure on Share Capital Increase With (Number) New Shares at (Price) Each Amasse Capital Holdings Ltd. has filed a next day disclosure return with the Hong Kong Stock Exchange, reporting changes in its issued ordinary shares. The company disclosed the total number of new shares issued and the issue price per share, in accordance with listing rules. Specific details regarding the total number of new shares and the issue price were not provided in the filing. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amasse Capital Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260203-12011513), on February 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) ### Related Stocks - [08168.HK](https://longbridge.com/en/quote/08168.HK.md) ## Related News & Research - [Amasse Capital Holdings Announces CEO Resignation and Board Appointments](https://longbridge.com/en/news/274528576.md) - [Joinn Laboratories sets board meeting to review first-quarter results](https://longbridge.com/en/news/283118236.md) - [Xuanzhu Biopharma wins HKEX approval to list 357,245,794 converted H shares](https://longbridge.com/en/news/283112742.md) - [Hagar hosts investor presentation on FY2025/26 results, Q4 earnings](https://longbridge.com/en/news/283110626.md) - [Hiroshima Venture Capital co-hosts TSUNAGU Hiroshima open-innovation matchmaking conference](https://longbridge.com/en/news/283097728.md)